Not all dividend cuts are created equal though.
In Yellow Pages' case, I'm pretty sure management at one point promised/suggested the distribution would be safe through 2011 (conversion to corp) and beyond.
In Biovail's case, management had explicitly explained to shareholders a few months back that acquisition(s) in this environment would carry a higher priority over maintaining the dividends. This week they followed through with that plan by buying the rights to Wellbutrin XL in US, and cutting distribution. No idea why shares were down 13% right after announcement, but at least they're rising back.
In Yellow Pages' case, I'm pretty sure management at one point promised/suggested the distribution would be safe through 2011 (conversion to corp) and beyond.
In Biovail's case, management had explicitly explained to shareholders a few months back that acquisition(s) in this environment would carry a higher priority over maintaining the dividends. This week they followed through with that plan by buying the rights to Wellbutrin XL in US, and cutting distribution. No idea why shares were down 13% right after announcement, but at least they're rising back.